Intelligent Bio Solutions Inc. cash flow to debt ratio of -3.43K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Intelligent Bio Solutions Inc.'s free cash flow has decreased 1.19% from $-9.79M last year to $-9.91M, signaling decreasing performance

Intelligent Bio Solutions Inc.'s debt to equity ratio is 0.21, which means that the company's assets are healthy financed, signaling financial stability.

Intelligent Bio Solutions Inc.'s debt has increased relative to shareholder equity from 0.14 last year to 0.21 today, signaling weakened financials

Intelligent Bio Solutions Inc. has a net cash position, so leverage is healthy.

Intelligent Bio Solutions Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Intelligent Bio Solutions Inc.'s profit margin has increased (-9.08%) in the last year from -326.40% to -296.76%, signaling increasing performance

Intelligent Bio Solutions Inc.'s short-term liabilities of $5.35M exceed its short-term assets of $4.14M, signaling financial risk

Intelligent Bio Solutions Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Intelligent Bio Solutions Inc.'s return on equity of -174.16%, is lower than 15.00%, indicating bad performance

Intelligent Bio Solutions Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Intelligent Bio Solutions Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Intelligent Bio Solutions Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Intelligent Bio Solutions Inc. has negative free cash flow, indicating cash burn

Intelligent Bio Solutions Inc.'s yearly earnings has decreased 4.06% since last year from $-10.16M to $-10.57M, signaling decreasing performance

Intelligent Bio Solutions Inc.'s yearly revenue has decreased 1.91% since last year from $3.11M to $3.05M, signaling decreasing performance

ROIC -110.43% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Intelligent Bio Solutions Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Intelligent Bio Solutions Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Intelligent Bio Solutions Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Intelligent Bio Solutions Inc. has insufficient data to evaluate this check.

Intelligent Bio Solutions Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Intelligent Bio Solutions Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Intelligent Bio Solutions Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Intelligent Bio Solutions Inc. has insufficient data to evaluate this check.

Intelligent Bio Solutions Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Intelligent Bio Solutions Inc. has a price-to-book ratio of 0.36x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Intelligent Bio Solutions Inc. has a price-to-sales ratio of 0.80x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue